Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
New hope for patients with incurable and disabling Dupuytren’s disease

New hope for patients with incurable and disabling Dupuytren’s disease

Publication Research

Scientists in the Kennedy Institute, NDORMS show anti-TNF inhibits the cells responsible for Dupuytren’s disease.

New method to study the behaviour of soluble molecules in tissues

New method to study the behaviour of soluble molecules in tissues

Publication Research

Researchers at the Kennedy Institute and the University of York develop a new imaging approach that offers superior resolution to track the movement of soluble proteins in tissues.

A workshop for curing arthritis sooner

A workshop for curing arthritis sooner

Department Research

Researchers from the Universities of Oxford and Birmingham joined forces with colleagues from seven NHS organisations at a workshop in Oxford to discuss an innovative new approach to inflammatory disease research.

Wellcome Trust Sir Henry Dale Fellowship awarded to Kennedy Researcher

Wellcome Trust Sir Henry Dale Fellowship awarded to Kennedy Researcher

Funding Research

We would like to congratulate Dr Luke Jostins-Dean on being awarded a 5-year Sir Henry Dale fellowship, joint funded by the Wellcome Trust and Royal Society, entitled ‘combining genetics and high-resolution cell phenotyping to map pathways underlying inflammatory bowel disease’.

Immune cells are natural networkers

Immune cells are natural networkers

Publication Research

New research published in Cell Reports by the Dustin Group has discovered a new way for immune cells to relay information about infection or genetic mutations through dynamic, yet durable cell contacts before deciding how to respond.

A secreted commensal sugar sweetens the deal for intestinal macrophages

A secreted commensal sugar sweetens the deal for intestinal macrophages

Department Publication Research

A recent publication from the Powrie group at the Kennedy Institute of Rheumatology has described a novel mechanism by which the commensal pathogen Heliobacter hepaticus maintains its niche in the intestinal environment.

Oxford-Elysium Fellowship in Autophagy

Oxford-Elysium Fellowship in Autophagy

Funding Research

Congratulations to Hanlin Zhang for being awarded the first Oxford-Elysium Fellowship in cellular health.

Autophagy-dependent generation of free fatty acids is critical for normal neutrophil differentiation

Autophagy-dependent generation of free fatty acids is critical for normal neutrophil differentiation

Publication Research

Recent research from the Simon Group has discovered an unexpected novel role that autophagy plays during the generation of neutrophils.

ARUK award two Clinical Fellowships looking into Osteoarthritis of the Hand.

ARUK award two Clinical Fellowships looking into Osteoarthritis of the Hand.

Department Funding Research oacentre

Congratulations to our new ARUK Clinical Research Fellows, Dr Malvika Gulati and Miss Jennifer Lane on their successful Fellowship applications.

Kennedy Institute investigator receives MRC Career Development Award

Kennedy Institute investigator receives MRC Career Development Award

Awards Research

Dr Anjali Kusumbe has been awarded an MRC Career Development Award to support her research examining how blood vessels support bone growth and repair.

Expanding clinical research at the Kennedy Institute

Expanding clinical research at the Kennedy Institute

Department Funding Research

Christopher Buckley joins the Kennedy Institute as a new Director of Clinical Research from May 2017.

New potential treatment target for patients with inflammatory bowel disease

New potential treatment target for patients with inflammatory bowel disease

Publication Research

A new study published today in Nature Medicine could change the lives of millions of people living with inflammatory bowel diseases (IBD) who don’t respond to the current standard of care.

Getting it 'just right' in the immune system

Getting it 'just right' in the immune system

Publication Research

Two Kennedy Institute scientists have proposed a solution to a puzzle of the human immune system: how our immune system scales its response in proportion to any threat to our health to make it 'just right'. Their ideas, published in the journal Trends in Immunology, could support a range of medical research.

New approach for type 2 diabetes research

New approach for type 2 diabetes research

Funding Research

A new interdisciplinary Oxford research programme will explore the relationship between metabolism and inflammation in metabolic diseases.

Oxford strengthens international collaboration to solve epidemic global health problem

Oxford strengthens international collaboration to solve epidemic global health problem

Funding Research

An innovative £3.9m research project funded by Novo Nordisk Foundation will explore the relationship between metabolism and inflammation in metabolic diseases.

Blood test that could predict arthritis

Blood test that could predict arthritis

Publication Research

Scientists have found a marker that can indicate your likelihood of suffering from rheumatoid arthritis (RA) even sixteen years before the condition takes effect.

Oxford osteoarthritis patients in new clinical trial

Oxford osteoarthritis patients in new clinical trial

Research

People in Oxford who have osteoarthritis of the knee are being invited to take part in a national charity-funded clinical trial to find a more effective treatment.

New funding for arthritis research

New funding for arthritis research

Awards Funding Research

Three researchers at the Kennedy Institute have been awarded grants by Arthritis Research UK to continue the fight against various forms of arthritis.

New hope for patients with cancer-induced bone diseases

New hope for patients with cancer-induced bone diseases

Publication Research

Researchers at the Kennedy Institute, part of NDORMS have repurposed the approved drug miglustat to successfully slow the progression of multiple myeloma.

Load More +